nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxemia—Methotrexate—ankylosing spondylitis	0.0425	0.0425	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisolone—ankylosing spondylitis	0.0295	0.0295	CcSEcCtD
Cisatracurium Besylate—Trauma—Triamcinolone—ankylosing spondylitis	0.0271	0.0271	CcSEcCtD
Cisatracurium Besylate—Trauma—Methylprednisolone—ankylosing spondylitis	0.0271	0.0271	CcSEcCtD
Cisatracurium Besylate—Trauma—Dexamethasone—ankylosing spondylitis	0.0246	0.0246	CcSEcCtD
Cisatracurium Besylate—Trauma—Betamethasone—ankylosing spondylitis	0.0246	0.0246	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisone—ankylosing spondylitis	0.0214	0.0214	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisolone—ankylosing spondylitis	0.02	0.02	CcSEcCtD
Cisatracurium Besylate—Myopathy—Triamcinolone—ankylosing spondylitis	0.0184	0.0184	CcSEcCtD
Cisatracurium Besylate—Myopathy—Methylprednisolone—ankylosing spondylitis	0.0184	0.0184	CcSEcCtD
Cisatracurium Besylate—Myopathy—Dexamethasone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Cisatracurium Besylate—Myopathy—Betamethasone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—ankylosing spondylitis	0.016	0.016	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisone—ankylosing spondylitis	0.0146	0.0146	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Methotrexate—ankylosing spondylitis	0.0134	0.0134	CcSEcCtD
Cisatracurium Besylate—Wheezing—Triamcinolone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisolone—ankylosing spondylitis	0.0111	0.0111	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.0105	0.0105	CcSEcCtD
Cisatracurium Besylate—Injury—Triamcinolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Cisatracurium Besylate—Injury—Methylprednisolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.0097	0.0097	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00969	0.00969	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00967	0.00967	CcSEcCtD
Cisatracurium Besylate—Injury—Betamethasone—ankylosing spondylitis	0.00926	0.00926	CcSEcCtD
Cisatracurium Besylate—Injury—Dexamethasone—ankylosing spondylitis	0.00926	0.00926	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisolone—ankylosing spondylitis	0.009	0.009	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00892	0.00892	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.0089	0.0089	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.0088	0.0088	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.0088	0.0088	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00827	0.00827	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00826	0.00826	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00809	0.00809	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00809	0.00809	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisone—ankylosing spondylitis	0.00807	0.00807	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00796	0.00796	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00751	0.00751	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00751	0.00751	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisolone—ankylosing spondylitis	0.00718	0.00718	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00705	0.00705	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisone—ankylosing spondylitis	0.00654	0.00654	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00636	0.00636	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisolone—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Dexamethasone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Betamethasone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00588	0.00588	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Cisatracurium Besylate—Erythema—Triamcinolone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Cisatracurium Besylate—Erythema—Methylprednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Betamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisolone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisone—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Cisatracurium Besylate—Angioedema—Triamcinolone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Cisatracurium Besylate—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Cisatracurium Besylate—Erythema—Dexamethasone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Cisatracurium Besylate—Erythema—Betamethasone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Cisatracurium Besylate—Convulsion—Triamcinolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Cisatracurium Besylate—Hypertension—Triamcinolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Cisatracurium Besylate—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Cisatracurium Besylate—Flushing—Prednisone—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Cisatracurium Besylate—Angioedema—Dexamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Cisatracurium Besylate—Angioedema—Betamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Prednisone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Prednisone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Cisatracurium Besylate—Convulsion—Dexamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Cisatracurium Besylate—Convulsion—Betamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Cisatracurium Besylate—Hypertension—Dexamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Cisatracurium Besylate—Hypertension—Betamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Betamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Cisatracurium Besylate—Hypotension—Dexamethasone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Cisatracurium Besylate—Hypotension—Betamethasone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Cisatracurium Besylate—Urticaria—Triamcinolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Cisatracurium Besylate—Urticaria—Betamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cisatracurium Besylate—Urticaria—Dexamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cisatracurium Besylate—Pruritus—Triamcinolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Cisatracurium Besylate—Pruritus—Betamethasone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Cisatracurium Besylate—Pruritus—Dexamethasone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Cisatracurium Besylate—Rash—Triamcinolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cisatracurium Besylate—Rash—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Cisatracurium Besylate—Rash—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cisatracurium Besylate—Rash—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cisatracurium Besylate—Pruritus—Prednisone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
